Teneligliptin in Early Diabetic Kidney Disease: An Observation in Asian Indian Patients with Type 2 Diabetes Mellitus in Real-Life Scenario

Journal Title: Journal of Clinical and Diagnostic Research - Year 2017, Vol 11, Issue 6

Abstract

Introduction: Teneligliptin is a recently developed Dipeptidyl Peptidase 4 (DPP4) inhibitor. Teneligliptin is suitable for glycaemic control in Type 2 Diabetes Mellitus (T2DM) patients with renal impairment including end stage renal disease. Aim: To assess the efficacy and safety of teneligliptin in Asian Indian T2DM patients with early Diabetic Kidney Disease (DKD). Materials and Methods: This was a single centre, retrospective analysis of patients with early DKD, who received teneligliptin 20 mg once daily for 24 weeks. Data related to glycaemic parameters, kidney function, lipid levels, retinopathy, neuropathy and safety variables available at 12 and 24 weeks were analysed. Descriptive statistical analysis was carried out. Statistical significance was assessed at a 5% level. Results: Total 37 patients (21 males; 16 females) were analysed. Compared to baseline, significant reduction in Fasting Plasma Glucose (FPG) (mg/dl) (143.89±28.26 vs 125.78±20.52, p=0.001); Postprandial Glucose (PPG) (mg/dl) (200.62±41.88 vs 165.76±26.02, p=0.001); Glycated Haemoglobin (HbA1c) (%) (8.65±0.58 vs 8.17±0.54, p=0.001) was noted at 12 weeks. This trend was further continued for 24 weeks with significant reduction in mean FPG, PPG and HbA1c to 113.73±16.82 mg/dl (p=0.008); 142.95±20.76 mg/dl (p=0.001); and 7.65±0.45% (p=0.001) respectively. Significant improvement in serum creatinine (mg/ dl) (2.45±0.27 vs. 2.26±0.23, p=0.001) and eGFR (CKD-EPI), (ml/ min/1.73 m2 ) (53.35±4.24 vs. 55.08±4.19, p=0.001) was noted at 12 weeks and continued for 24 weeks with reduction in serum creatinine of 0.37±0.18 mg/dl (p=0.001) and increase of eGFR of 4.60±1.59 ml/min/1.73 m2 (p=0.001). At baseline, proteinuria was noted in all patients while at 24 weeks, 40.5% (p=0.001) patients did not report proteinuria. Significant improvements in lipid parameters with no deterioration in retinopathy and subjective improvement in peripheral neuropathy was also noted. No adverse events were noted. Conclusion: Teneligliptin reported significant and sustained improvement in glycaemic control in Asian Indian Patients of T2DM with early DKD and was well tolerated. Additionally, Teneligliptin reported significant improvement in renal function.

Authors and Affiliations

Kiran Shah

Keywords

Related Articles

Measurement of Health Related Quality of Life in Malaria Patients in Indonesia using EQ-5D-5L

ABSTRACT Introduction: Indonesia is one of the countries with high malaria cases. In 2017 there were at least 261,167 malaria cases nationally. West Papua is included in the 3 major provinces with the highest incidence o...

Chryseobacterium Indologenes Pneumonitis in an Infant: A Case Report

Chryseobacterium indologenes, a non-fermentative Gram-negative bacilli distributed widely in nature, is an emerging nosocomial pathogen, inherently resistant to a wide range of antibiotics. There is limited number of C....

Spontaneous Inguinal Faecal Fistula due to Incarcerated Richter’s Hernia-Managed Conservatively

ABSTRACT Spontaneous enterocutaneous fistula due to strangulated inguinal Richter’s hernia is a rare presentation and occurs mostly either due to ignorance of the patients or delay in seeking timely medical intervention....

Bone Mineral Density among Lean Type II Diabetes Mellitus Patients-A Cross-sectional Comparative Study

ABSTRACT Introduction: In case of diabetes mellitus, the pathological process behind fragility of the bone are complex. This process is found to be mediated by various factors like hyperglycaemia, oxidative stress and th...

An In vitro Comparative Evaluation of Flexural Strength of Monolithic Zirconia after Surface Alteration Utilising Two Different Techniques

Introduction: Chairside surface alteration like grinding is often done by clinicians for adjustment of zirconia restorations. To restore the surface of the prostheses, either polishing or glazing is done. However, there...

Download PDF file
  • EP ID EP349167
  • DOI 10.7860/JCDR/2017/27013.10003
  • Views 62
  • Downloads 0

How To Cite

Kiran Shah (2017). Teneligliptin in Early Diabetic Kidney Disease: An Observation in Asian Indian Patients with Type 2 Diabetes Mellitus in Real-Life Scenario. Journal of Clinical and Diagnostic Research, 11(6), 22-25. https://europub.co.uk/articles/-A-349167